ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 201459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 201459; 2) Community: the network communities that were significantly associated with the response to NSC 201459; 3) Molecule: the relationships between components within communities and NSC 201459; 4) MDR: the compounds that were significantly associated with the NSC 201459.

NSC Compound Enrichment Correlation
NSC 136468 Null 0.0241085022307781 0.56035237
NSC 113497 16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) 0.0247979034812109 0.25058202
NSC 114346 Null 0.0247979034812109 0.27147709
NSC 244404 Null 0.0247979034812111 0.4205482
NSC 300289 Pinafide 0.0247979034812111 0.14446354
NSC 30915 Null 0.0247979034812111 0.49741749
NSC 313681 Oxiperomide(USAN) 0.0247979034812111 -0.0091610442
NSC 328410 Camptothecin Derivative 0.0247979034812111 0.14773666
NSC 32951 Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone 0.0247979034812111 0.42783233
NSC 339137 PHYSALOLACTONE 0.0247979034812111 0.40427713
Total:126  Current:76    [First] [Prev] [Next] [Last]